EUVIMEDEUVIMED entdecken
Open Access

Polygenic Risk and Coronary Artery Disease Severity

Alborz Sherafati iD, Kristjan Norland iD, Mohammadreza Naderian iD, Daniel J Schaid iD, Iftikhar J Kullo iD

Circulation: Genomic and Precision Medicine · 2024

DOI: 10.1161/circgen.123.004470 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Genomic and Precision Medicine, 2024. Verfasst von Alborz Sherafati und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine (A.S., K.N., M.N., I.J.K.). Hauptthemen laut MEDLINE: Coronary Artery Disease, Multifactorial Inheritance, Severity of Illness Index. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, NHGRI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Coronary atherosclerotic burden and adverse coronary heart disease events are related phenotypes with likely shared genetic cause. METHODS: We analyzed 6021 patients with available coronary angiography, genotyping, and exome sequencing data. We tested for associations of polygenic risk scores for coronary heart disease (PRS CHD ) with multiple measures of coronary artery disease (CAD) severity. We assessed the joint associations of PRS CHD and pathogenic/likely pathogenic variants in 3 familial hypercholesterolemia genes, with CAD severity. We performed mediation analyses to explore whether CAD severity mediated the association of PRS CHD with prevalent coronary heart disease and incident myocardial infarction. RESULTS: A 1-SD increase in PRS CHD was associated with multiple measures of CAD severity, including the log Gensini score (β, 0.31 [95% CI, 0.28–0.33]). Carrying a pathogenic/likely pathogenic familial hypercholesterolemia variant was associated with a higher log Gensini score after adjustment for PRS CHD (β, 0.21 [95% CI, 0.03–0.38]). A 1-SD increase in PRS CHD was associated with incident myocardial infarction over a mean follow-up of 9.2 years (hazard ratio, 1.20 [95% CI, 1.13–1.27]; P =5×10 − 10 ), and the Gensini score mediated 90% of this association. CONCLUSIONS: PRS CHD was associated with multiple measures of CAD severity. The association of PRS CHD with incident myocardial infarction was almost fully mediated by CAD severity, indicating a considerable genetic overlap between the 2 phenotypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseMultifactorial InheritanceSeverity of Illness IndexHumansFemaleMaleMiddle AgedAgedMyocardial InfarctionGenetic Predisposition to DiseaseRisk FactorsHyperlipoproteinemia Type IIProprotein Convertase 9

Stichwörter der Autor:innen

coronary artery diseaseexomegeneticshypercholesterolemiamediation analysismyocardial infarctionpolygenic risk score

Substanzen

Proprotein Convertase 9

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine (A.S., K.N., M.N., I.J.K.).
  • Department of Health Sciences Research (D.J.S.).
  • Gonda Vascular Center, Mayo Clinic, Rochester, MN (I.J.K.).

ORCID-Profile: Alborz Sherafati, Kristjan Norland, Mohammadreza Naderian, Daniel J Schaid, Iftikhar J Kullo

Förderung

  • NHLBI NIH HHS
  • NIGMS NIH HHS
  • NHGRI NIH HHS

Zitieren

APA

Sherafati, A., Norland, K., Naderian, M., Schaid, D. J., & Kullo, I. J. (2024). Polygenic Risk and Coronary Artery Disease Severity. Circulation: Genomic and Precision Medicine. https://doi.org/10.1161/circgen.123.004470

Vancouver

Sherafati A, Norland K, Naderian M, Schaid DJ, Kullo IJ. Polygenic Risk and Coronary Artery Disease Severity. Circulation: Genomic and Precision Medicine. 2024. doi:10.1161/circgen.123.004470

BibTeX
@article{Sherafati2024,
  author = {Sherafati, Alborz and Norland, Kristjan and Naderian, Mohammadreza and Schaid, Daniel J and Kullo, Iftikhar J},
  title = {Polygenic Risk and Coronary Artery Disease Severity},
  journal = {Circulation: Genomic and Precision Medicine},
  year = {2024},
  doi = {10.1161/circgen.123.004470}
}
Kostenlos starten →